Interferon Beta-1A
This recombinant interferon used to treat relapsing forms of multiple sclerosis (MS) works by modulating the immune system to reduce the frequency and severity of relapses and slow disability progression. It is thought to reduce the migration of immune cells across the blood-brain barrier and suppress inflammatory activity in the nervous system. It is administered by intramuscular or subcutaneous injection.
Therapeutische Bereiche
Wirkmechanismus
As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Häufig gestellte Fragen
This recombinant interferon used to treat relapsing forms of multiple sclerosis (MS) works by modulating the immune system to reduce the frequency and severity of relapses and slow disability progression. It is thought to reduce the migration of immune cells across the blood-brain barrier and suppress inflammatory activity in the nervous system. It is administered by intramuscular or subcutaneous injection.
As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.
Yes, Interferon Beta-1A is an approved drug. It has reached clinical phase 4. It is classified as a Protein.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201562. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="interferon-beta-1a"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/interferon-beta-1a/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/interferon-beta-1a/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/interferon-beta-1a/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="interferon-beta-1a"></drugfyi-drug>